How to Choose the Right MS Specialist with Medicare

- 42% of MS patients aren't seeing an MS specialist, with 33% unable to find one in their community
- The US faces a severe neurologist shortage with only 598 new specialists added over the last decade
- Medicare Advantage plans cover only 33% of newer MS drugs compared to 81% for older medications
- Initial prior authorization denials reach 50%, but 82% succeed on appeal when patients pursue them
- A Solace MS advocate can help navigate specialist searches, insurance appeals, and coordinate your MS care
Finding the right multiple sclerosis specialist when you're on Medicare can feel overwhelming. Between doctor shortages, insurance networks, and complex coverage rules, many patients struggle to get the specialized care they need. But with the right approach and resources, you can successfully connect with an MS expert who understands both your condition and your Medicare benefits.

The Challenge of Finding MS Specialists
The numbers tell a concerning story about MS specialist access in America. A 2024 nationwide survey found that 42% of MS patients were not receiving care from an MS specialist, with many citing inability to find specialists in their community or afford care. This access crisis stems from multiple factors working against patients.
The neurologist shortage has reached critical levels. Over the last decade, only 598 neurologists were added to the US workforce while demand increased substantially. The situation is projected to worsen, with the American Academy of Neurology warning of a 19% neurologist shortage by 2025. Wait times for new patient appointments averaged 35 business days in 2012 and have likely grown since.
Geographic barriers compound the problem. Research on over 560,000 Medicare beneficiaries found that 17% traveled an average of 81 miles one way to see a neurologist. Rural patients face even starker challenges, with 22% traveling more than 60 miles each way for infusion treatments.
Understanding Your Medicare Options
Your Medicare coverage type significantly impacts both specialist access and costs. The choice between Original Medicare and Medicare Advantage affects everything from which doctors you can see to how much you'll pay for treatments.
Original Medicare provides unrestricted provider choice—you can see any doctor, specialist, or hospital accepting Medicare anywhere in the United States without referrals or network restrictions. Since 96% of eligible physicians participate in Medicare, access is rarely limited by insurance networks. However, Original Medicare has no out-of-pocket maximum, meaning you continue paying 20% coinsurance indefinitely.
Medicare Advantage plans offer capped out-of-pocket costs (averaging $4,882 for in-network services in 2024) but restrict you to network providers. About 56% of Medicare Advantage enrollees are in HMO plans that only cover in-network care except for emergencies.
The coverage differences become particularly important for MS medications. A 2024 analysis revealed that Medicare Advantage plans cover only 33% of newer MS drugs (approved since 2015) compared to 81% for older medications—a 48 percentage point gap. Traditional prescription drug plans show even worse coverage at just 11% for newer medications.
Practical Steps to Find an MS Specialist
Start your search with multiple complementary resources:
Use Official Medicare Tools:
- Medicare's Care Compare tool at medicare.gov/care-compare allows filtering by specialty and Medicare acceptance
- This database covers providers accepting Original Medicare with verified participation status
- For Medicare Advantage enrollees, start with your plan's provider directory through your insurer's website
Leverage MS-Specific Resources:
- The National MS Society's doctor finder identifies specialists and comprehensive care centers
- The Multiple Sclerosis Association of America helpline offers trained specialists available by phone, email, or live chat at no cost
- The MS Foundation operates helplines in English (888-673-6287) and Spanish (800-448-4727) with case workers who help identify Medicare-accepting providers
Consider Academic Medical Centers: Academic institutions with MS programs typically accept Medicare and offer specialized expertise. These include Johns Hopkins Multiple Sclerosis Center, NYU Langone MS Comprehensive Care Center, Cleveland Clinic's Mellen Center, and similar institutions. The Consortium of Multiple Sclerosis Centers represents over 250 member centers nationwide encompassing 12,000+ healthcare professionals.
When contacting potential specialists, ask essential verification questions: "Do you accept Original Medicare?" or "Do you accept my specific Medicare Advantage plan?" followed by "Are you accepting new Medicare patients?" Don't assume acceptance—providers can stop accepting new patients or drop insurance contracts.

Evaluating Specialist Credentials
Not all neurologists have equivalent MS expertise, and these differences directly affect treatment outcomes. Studies consistently show that MS specialists initiate treatment earlier, prescribe disease-modifying therapies more frequently, and provide better monitoring compared to general neurologists.
Look for these key qualifications:
Board Certification: Verify certification in neurology by the American Board of Psychiatry and Neurology at abpn.org. This confirms completion of medical school, neurology residency, and ongoing education.
Fellowship Training: Ask directly: "Did you complete a fellowship in MS or neuroimmunology?" Fellowship-trained specialists complete 1-3 additional years of subspecialty training at major academic medical centers, developing deep expertise in MS care.
Practice Focus: MS specialists typically treat 100+ patients annually, with at least 50% of their practice dedicated to MS. High-volume practices correlate with staying current on the approximately 20 FDA-approved MS medications.
Professional Affiliations: Membership in the Consortium of Multiple Sclerosis Centers (CMSC) or affiliation with National MS Society programs indicates ongoing commitment to MS care excellence.
Understanding MS Treatment Coverage
Medicare coverage for MS treatments splits between Part B and Part D based on how medications are given:
Part B Coverage:
- Covers infusion and injectable therapies given in medical settings
- Includes medications like Ocrevus, Tysabri, and Lemtrada
- Requires 20% coinsurance with no annual out-of-pocket maximum in Original Medicare
- For expensive infusions, this can mean $13,000+ annually in out-of-pocket costs
Part D Coverage:
- Covers oral and self-injectable medications you can take at home
- Includes drugs like Tecfidera, Gilenya, and Copaxone
- The 2025 Inflation Reduction Act provides a new $2,000 annual out-of-pocket maximum, down from over $3,300 in 2024
Medicare also covers essential MS-related services including neurologist visits, MRI scans, physical therapy, occupational therapy, and mental health counseling with 20% coinsurance after meeting the annual deductible.

Navigating Prior Authorization Challenges
Prior authorization represents one of the most frustrating barriers MS patients face. Initial denial rates reach approximately 50%, yet 82% of appeals result in full or partial approval when patients pursue them through higher levels. The catch: only 11% of patients actually appeal denials.
When facing authorization challenges:
Act Immediately:
- Request detailed written explanation of denial reasons
- Contact your neurologist's office within 24-48 hours
- File appeals before deadlines (typically 60-180 days)
- Request expedited review if treatment delay could harm your health
Build Strong Documentation:
- Gather complete medical history and MRI reports showing disease activity
- Document why previous treatments failed
- Include detailed letter of medical necessity from your neurologist
- The National MS Society provides template appeal letters through their MS Navigator program (1-800-344-4867)
Leverage Manufacturer Support:Most major MS drug manufacturers offer bridge programs providing free medication during appeals, sometimes for up to 24 months. These programs also provide dedicated case managers to help navigate authorization processes.
Financial Resources and Assistance
Several programs can help offset MS treatment costs:
Federal Programs:
- Medicare Extra Help (Low-Income Subsidy) reduces Part D premiums and copays for qualified individuals
- State Health Insurance Assistance Programs (SHIP) provide free Medicare counseling at 877-839-2675
Nonprofit Assistance:
- The HealthWell Foundation's MS Medicare Access Fund provides average grants of $3,000 for Medicare beneficiaries
- The Patient Access Network Foundation offers up to $5,000 annually for MS medication copays
- The Multiple Sclerosis Association of America provides equipment assistance and client services at 800-532-7667
Manufacturer Programs:Patient assistance programs exist for every major MS medication, providing free or discounted drugs for qualified patients. Contact information appears on each medication's official website.
When to Consider Out-of-Network Care
Going out-of-network may be worth considering when:
- No in-network MS specialists are available
- Accessing specialized expertise at MS Centers of Excellence
- Maintaining long-standing relationships with trusted specialists
- Living in rural areas with limited network options
For Original Medicare patients, out-of-network costs remain relatively modest—standard 20% coinsurance possibly plus 15% additional for non-participating providers.
For Medicare Advantage patients, particularly those in HMO plans, out-of-network costs can be prohibitive. However, you can request network exceptions when no comparable in-network specialist exists.

Red Flags to Avoid
Seek a different specialist if your current provider:
- Sees patients only annually (MS requires 2-4 visits yearly minimum)
- Doesn't order annual brain MRIs
- Never shows you MRI scans or explains results
- Doesn't screen for "invisible" MS symptoms like fatigue or cognitive issues
- Seems unfamiliar with newer MS therapies
- Rushes through appointments or dismisses concerns
- Delays treatment initiation without good clinical reason
Trust your instincts—if you don't feel heard, respected, or confident in the provider's expertise, seek a second opinion.
How a Solace Advocate Can Help
Navigating the Medicare system while managing MS can be overwhelming, but you don't have to do it alone. A Solace advocate can provide crucial support throughout your journey to find the right specialist and access appropriate care.
Your advocate can help you research and identify Medicare-accepting MS specialists in your area, verify insurance participation and network status, coordinate initial consultations and gather necessary medical records. When facing prior authorization challenges, they can assist with appeal documentation, coordinate with your neurologist's office, track authorization deadlines and requirements, and connect you with manufacturer bridge programs.
Solace advocates also provide ongoing care coordination by helping schedule appointments and follow-up care, organizing medical records from multiple providers, facilitating communication between your care team members, and identifying financial assistance programs and resources.
Most importantly, your advocate ensures nothing falls through the cracks during care transitions, keeps all providers informed about your treatment plan, and serves as your dedicated point of contact throughout the complex process of managing MS care with Medicare.

Frequently Asked Questions
What's the difference between a general neurologist and an MS specialist?MS specialists have additional fellowship training specifically in multiple sclerosis and neuroimmunology. They typically dedicate at least 50% of their practice to MS, treat 100+ MS patients annually, and stay current on the latest MS treatments and research. Studies show MS specialists provide earlier treatment initiation, better monitoring, and more comprehensive care compared to general neurologists.
Will Medicare cover my MS medications?Medicare covers MS medications through Part B (for infusions given in medical settings) and Part D (for oral and self-injectable medications). Coverage varies by specific medication and plan. The 2025 Inflation Reduction Act provides a new $2,000 annual out-of-pocket maximum for Part D medications, significantly reducing costs for many patients.
What should I do if my prior authorization gets denied?Don't accept the initial denial—82% of appeals succeed when patients pursue them. Contact your neurologist's office immediately, request a detailed written explanation of the denial, and file a formal appeal before the deadline. Consider requesting expedited review if treatment delay could harm your health. Manufacturer bridge programs can provide free medication during the appeals process.
How do I choose between Original Medicare and Medicare Advantage for MS care?Original Medicare offers unrestricted provider choice and minimal prior authorization requirements but has no out-of-pocket maximum. Medicare Advantage provides capped costs and often integrates prescription coverage but restricts you to network providers. For MS patients needing specialized care or expensive infusions, Original Medicare plus a Medigap supplement often provides better value and access.
Can I see an out-of-network MS specialist with Medicare?With Original Medicare, you can see any Medicare-accepting provider nationwide with standard 20% coinsurance. Medicare Advantage plans vary—HMO plans typically don't cover out-of-network care except emergencies, while PPO plans allow it with higher cost-sharing. You can request network exceptions from Medicare Advantage plans when no comparable in-network specialist exists.
This article is for informational purposes only and should not be substituted for professional advice. Information is subject to change. Consult your healthcare provider or a qualified professional for guidance on medical issues, financial concerns, or healthcare benefits.


Learn more about Solace and how a patient advocate can help you.
- PubMed Central: The Impact of Insurance Restrictions in Newly Diagnosed Individuals With Multiple Sclerosis
- Multiple Sclerosis Association of America: What's New in MS Research - July 2024
- AAN: US Facing a Neurologist Shortage
- Medscape: Is the US Neurologist Shortage Insurmountable?
- NCOA: What Are the Steps for Medicare Appeals?
- Avalere Health Advisory: Patterns in Patient Access to MS Drugs
- KFF: Medicare Advantage in 2024: Premiums, Out-of-Pocket Limits, Supplemental Benefits, and Prior Authorization
- Consortium of Multiple Sclerosis Centers: About Us
- NCBI: Closing the Part D Coverage Gap and Out-of-Pocket Costs for Multiple Sclerosis Drugs
- Neurology Live: Key Takeaways for MS Providers Regarding Major Medicare Changes Expected in 2025
- HealthWell Foundation: Multiple Sclerosis - Medicare Access
- State Health Insurance Assistance Programs: Get Medicare Help from Your Local SHIP Program
- Choosing Therapy: The National MS Society

.png)


